IFRX•benzinga•
Oppenheimer Initiates Coverage On InflaRx with Outperform Rating, Announces Price Target of $6
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 8, 2025 by benzinga